APA
Fasching P. A., Loibl S., Hu C., Hart S. N., Shimelis H., Moore R., Schem C., Tesch H., Untch M., Hilfrich J., Rezai M., Gerber B., Costa S. D., Blohmer J., Fehm T., Huober J., Liedtke C., Weinshilboum R. M., Wang L., Ingle J. N., Müller V., Nekljudova V., Weber K. E., Rack B., Rübner M., von Minckwitz G. & Couch F. J. (20191003). BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Chicago
Fasching Peter A, Loibl Sibylle, Hu Chunling, Hart Steven N, Shimelis Hermela, Moore Raymond, Schem Christian, Tesch Hans, Untch Michael, Hilfrich Jörn, Rezai Mahdi, Gerber Bernd, Costa Serban Dan, Blohmer Jens-Uwe, Fehm Tanja, Huober Jens, Liedtke Cornelia, Weinshilboum Richard M, Wang Liewei, Ingle James N, Müller Volkmar, Nekljudova Valentina, Weber Karsten E, Rack Brigitte, Rübner Matthias, von Minckwitz Gunter and Couch Fergus J. 20191003. BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Harvard
Fasching P. A., Loibl S., Hu C., Hart S. N., Shimelis H., Moore R., Schem C., Tesch H., Untch M., Hilfrich J., Rezai M., Gerber B., Costa S. D., Blohmer J., Fehm T., Huober J., Liedtke C., Weinshilboum R. M., Wang L., Ingle J. N., Müller V., Nekljudova V., Weber K. E., Rack B., Rübner M., von Minckwitz G. and Couch F. J. (20191003). BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
MLA
Fasching Peter A, Loibl Sibylle, Hu Chunling, Hart Steven N, Shimelis Hermela, Moore Raymond, Schem Christian, Tesch Hans, Untch Michael, Hilfrich Jörn, Rezai Mahdi, Gerber Bernd, Costa Serban Dan, Blohmer Jens-Uwe, Fehm Tanja, Huober Jens, Liedtke Cornelia, Weinshilboum Richard M, Wang Liewei, Ingle James N, Müller Volkmar, Nekljudova Valentina, Weber Karsten E, Rack Brigitte, Rübner Matthias, von Minckwitz Gunter and Couch Fergus J. BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20191003.